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Functional studyA number of genes responsible for hearing loss are related to ion recycling and homeostasis in the inner ear.
Connexins (Cx26 encoded by GJB2, Cx31 encoded by GJB3 and Cx30 encoded by GJB6) are core components of
gap junctions in the inner ear. Gap junctions are intercellular communication channels and important factors
that are associated with hearing loss. To date, a molecular genetics study of GJB3 and GJB6 as a causative gene
for hearing loss has not been performed in Korea. This study was therefore performed to elucidate the genetic
characteristics of Korean patients with nonsyndromic sensorineural hearing loss and to determine the path-
ological mechanism of hearing loss by analyzing the intercellular communication function of Cx30 and Cx31
variants. Sequencing analysis of the GJB3 and GJB6 genes in our population revealed a total of nine variants,
including four novel variants in the two genes. Three of the novel variants (Cx31-p.V27M, Cx31-p.V43M and
Cx-30-p.I248V) and two previously reported variants (Cx31-p.V84I and Cx30-p.A40V) were selected for
functional studies using a pathogenicity prediction program and assessed for whether the mutations were
located in a conserved region of the protein. The results of biochemical and ionic coupling tests showed
that both the Cx31-p.V27M and Cx31-p.V84I variants did not function normally when each was expressed
as a heterozygote with the wild-type Cx31. This study demonstrated that two variants of Cx31 were patho-
genic mutations with deleterious effect. This information will be valuable in understanding the pathogenic
role of GJB3 and GJB6 mutations associated with hearing loss.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
A number of genes responsible for hearing loss (HL) are related to ion
recycling and homeostasis in the inner ear [1]. Connexins (Cxs) aremem-
brane proteins and core components of gap junctions (GJs), which are
intercellular communication channels that are important for recycling
potassium ions from the hair cells to the endolymph during auditory
transduction [2–4]. GJs allow inorganic ions and small molecules with
molecular weights of less than 1 kDa to pass between adjacent cells
by nonspeciﬁc and passive diffusion [5]. Each GJ channel is composed of
two hemichannels, termed connexons and each hemichannel is com-
posed of six connexin (Cx) subunits that contain one cytoplasmic loop,
two extracellular loops, and four transmembrane domains, with the
amino- and carboxy-terminal ends facing the cytoplasm [6]. The trans-
membrane and extracellular loop domain sequences within the Cx gene+82 53 953 3066.
+82 53 953 3066.
k@knu.ac.kr (U-K. Kim).
rights reserved.family are conserved. The main differences between the Cx proteins are
the lengths and sequences of the cytoplasmic loop and the carboxyl-
terminal domain [7–11]. The hemichannel is formed from either iden-
tical (homomeric) or different (heteromeric) Cx proteins, and two
hemichannels dock together with identical (homotypic) or different
(heterotypic) connexons [12]. Because of the various possible combina-
tions, each GJ channel shows considerable functional differences with
distinct permeabilities [13,14].
To date, many studies have been performed on variants of Cx26
(gap junction beta-2 protein) which is encoded by the GJB2 gene
[15]. The GJB2 gene accounts for approximately 50% of the autosomal
recessive nonsyndromic HL cases in Caucasians [16]. However, it only
accounts for 10–15% of the nonsyndromic HL cases in Koreans [17],
suggesting an ethnic difference between Koreans and Caucasians.
The gap junction beta-6 (Cx30, encoded by GJB6) is co-expressed
with Cx26 in the ﬁbrocytes of the spiral ligament, basal cells of stria
vascularis, spiral limbus, and supporting cells in the organ of Corti
[18]. However, expression of the gap junction beta-3 (Cx31, encoded
by GJB3) and Cx26 only shows the similar pattern in ﬁbrocytes of the
spiral ligament and spiral limbus [19]. Furthermore, it has been
Table 1
The GJB3 and GJB6 variations detected in Koreans.
Gene Nucleotide
change
Amino acid
change
Genotype distributiona dbSNPb
Patients Controls
GJB3 c.79G>A p.V27M 0/1/211 0/0/63 –
c.127G>A p.V43M 0/1/211 0/1/62 –
c.250G>A p.V84I 0/7/205 0/0/63 rs145751680
c.357C>T p.N119N 1/34/177 0/11/52 rs41310442
c.580G>A p.A194T 0/7/208 0/2/66 rs117385606
c.813+43A>C – 200/15/0 67/1/0 rs41266429
c.813+53A>G – 149/53/13 47/16/5 rs476220
GJB6 c.261A>T p.P87P 0/1/197 0/0/57 –
c.742A>G p.I248V 0/1/197 0/0/57 –
a Genotype distribution: numbers indicate homozygous/heterozygous/wild type.
b dbSNP is Single Nucleotide Polymorphism database and the reference ID number
for the National Center for Biotechnology Information (NCBI) is presented.
286 S-K. Oh et al. / Biochimica et Biophysica Acta 1832 (2013) 285–291determined that the variants of other Cx proteins in addition to Cx26
also alter the function of GJs and affect inner ear function [20]. How-
ever, only a few genetic and functional studies have been performed
on Cx31 and Cx30 variants in other countries. Moreover, neither ge-
netic nor functional studies of these proteins have been performed
in Korea. Therefore, this study investigated the GJB3 (encoding
Cx31) and GJB6 (encoding Cx30) genes that are expressed in the
inner ear and associated with HL.
The work was performed to determine the genetic characteristics of
Koreans with nonsyndromic sensorineural HL and the evaluation of the
pathogenicity of GJB3 and GJB6 sequence variants through functional
studies.
2. Materials and methods
2.1. Subjects and molecular genetic analysis
A total of 215 unrelated Korean patients with nonsyndromic
sensorineural HL from the Kyungpook National University Hospital
were included in this study. All participants provided written in-
formed consent according to the protocol approved by the Institu-
tional Review of Board of Kyungpook National University Hospital
prior to the study. In total, 68 unrelated Koreans with normal hearing
diagnosed by pure tone audiometry (PTA) test were recruited for use as
control subjects. Genomic DNA was extracted from peripheral blood
using a FlexiGene DNA extraction kit (Qiagen, Hilden, Germany).
The GJB3 and GJB6 coding regions were ampliﬁed by polymerase
chain reaction (PCR) using the following designed primers: F1-5′CCCAG
TTCCC AGTGT CAAAA3′, R1-5′TACGA CAACG CAGGC AAGA3′, F2-5′
TAGGT CGGGC AATGT AGCA3′ and R2-5′GAACT CAGAA CACTG CCTGG
T3′ (for GJB3) and F-5′GGTTG GTATT GCCTT CTGGA3′ and R-5′TAGGG
ATAAA CCAGC GCAAT3′ (for GJB6). An ABI 3130XL DNA sequencer was
used to assay the products, and the datawere analyzedwith the Chromas
Pro program and the Basic Local Alignment Search Tool (BLAST) on the
NCBI website (http://www.ncbi.nlm.nih.gov/).
The variants for the functional studies were evaluated for potential
pathogenicity using SNPs3D (http://www.snps3d.org) and PhD-SNP
(http://gpcr.biocomp.unibo.it/~emidio/PhD-SNP/PhD-SNP.htm), andpro-
tein conservation was evaluated using CLC Sequence Viewer (v.6.0.1),
a multiple sequence alignment program.
2.2. Molecular cloning and transfection
ThehumanCx31 andCx30 cDNAswere subcloned into the pmCherry-
N1 and pEGFP-N1 vectors, respectively (Clontech Inc., Mountain View,
CA, USA), and each variant of Cx31 and Cx30 was generated according
to the site-directed mutagenesis manual. The sequences of the con-
structed vectors were conﬁrmed using Sanger sequencing.
The human embryonic kidney cell line, HEK293, and the human
cervical cancer cell line, HeLa, were used for transfection of the
Cx31 and Cx30 constructs, respectively, and were obtained from the
Korean Cell Line Bank (Seoul, Korea). These cell lines are widely
used for GJ studies because they lack endogenous expression of Cxs.
The cells were seeded on a cover slip in 24-well plate and cultured
to 80% conﬂuence one day before transfection. The cells were trans-
fected using the Fugene HD reagent (Roche Diagnostics, Indianapolis,
IN, USA) following the manufacturer's instructions.
2.3. Assays for measuring biochemical and ionic coupling
GJ biochemical coupling wasmeasured using a single cell dye trans-
fer assay. One of the two adjoining cells forming a GJ in Hanks' balanced
salt solution (HBSS) containing 1.2 mM CaCl2, 1 mM MgCl2 and 5 mM
HEPES, adjusted to pH 7.4 with NaOH (external solution) was analyzed
by patch-clamp using a micro electrode ﬁlled with a 1% Lucifer Yellow
(LY, molecular weight 457, charge −2; Sigma) solution or with0.15 mMpropidium iodide (PI, molecular weight 650, charge+2; Invi-
trogen) in internal solution (120 mM KCl, 1 mM MgCl2 and 5 mM
HEPES in HBSS). The LY transfer was recorded for 0.5–3 min after injec-
tion by electrophoresis using a method based on the technique de-
scribed by Haas [21] and the PI transfer was recorded for 1–5 min.
Transfected cells grown on cover slips were loaded with the calcium
indicator dye, fura-2 acetoxymethyl ester (fura-2AM, 5 μM), and pluronic
F-127 which was used to help disperse fura-2AM in HBSS (containing
1.2 mM CaCl2, 1 mMMgCl2 and 5 mMHEPES). The cells were then incu-
bated for 30 min at room temperature under constant agitation. The cells
were then placed in HBSS including 200 μM suramin (external solution),
which blocks intercellular Ca2+ signaling through a purinergic receptor
[18]. This solution was also used as the pipette solution. Mechanical
stimulation was performed by lightly touching one cell membrane, and
calcium image was analyzed using Axon Imaging Workbench software
(version 6.0, Axon Instruments, CA).
3. Results
3.1. Sequencing analysis and selection of variants used in the functional
study
From the results of the analysis of theGJB3 andGJB6 gene sequences in
Korean patients with nonsyndromic HL, seven variants in the GJB3 and
two variants in the GJB6 were identiﬁed, and two novel variants were
detected in each gene (Table 1). The p.V27M and p.V84I variants in GJB3
and thep.I248Vvariants inGJB6werenot observed innormalKorean con-
trols. These variants also contained nonsynonymous substitutions; there-
fore, it is likely that they affected the tertiary structure of the Cx protein
and the formation of a hemichannel or a GJ. To evaluate the evolutionary
conservation of the amino acid substitutions, the amino acid sequences of
Cx genes obtained from seven species were aligned (Fig. S1). The p.V27M
and p.V84I variants in GJB3, but not the p.I248V variant in GJB6, are locat-
ed in evolutionarily conserved position of the Cx gene family across the
seven species, and these variants are also predicted to be pathogenic by
SNPs3D and PhD-SNP (Table 2). These three variants in addition to
Cx31-p.V43M used as a control and Cx30-p.A40V on which no functional
studies have been performed were selected for functional studies. Thus,
ﬁve variants (p.V27M, p.V43M and p.V84I of Cx31 and p.A40V and
p.I248V of Cx30) were assessed to clarify their possible roles in HL.
3.2. Assays for measuring biochemical coupling
HEK293 cells were transfected with expression plasmids encoding
wild-type (WT) Cx31 and three mutated (MT) Cx31 constructs tagged
withmCherry, a red ﬂuorescent protein marker, to identify the location
of the Cx proteins in HEK293 cells. We observed that the Cx31-WT-
mCherry and the three Cx31-MT-mCherry proteins were localized on
the cell membrane and formed GJs as shown by the characteristic
Table 2
The Cx31 and Cx30 variants selected for functional study.
Protein Amino acid
change
Domaina Pathogenicity prediction Reference
SNPs3Db PhD-SNPc
Cx31 p.V27M TM1 −0.44 Disease 3 This study
p.V43M EC1 −0.44 Neutral 0 This study
p.V84I TM2 −1.02 Disease 1 Chu et al. (2001)
Cx30 p.A40V TM1 −0.67 Neutral 2 Wang et al. (2011)
p.I248V COOH 1.34 Neutral 3 This study
a Abbreviations: TM — transmembrane, EC — extracellular loops, COOH — carboxy-
terminal.
b SNPs3D: positive score indicates a non-deleterious variant and a negative score
indicates a deleterious variant.
c PhD-SNP (Predictor of human Deleterious Single Nucleotide Polymorphisms) classiﬁes
variants as disease-related (Disease) or as neutral polymorphisms (Neutral).
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GJs regardless of the protein domain in which the mutations occurred.
The biochemical coupling test of WT and mutated GJ channels was
performed by examining the cell-to-cell diffusion of Lucifer Yellow
(LY), a cell membrane-impermeable ﬂuorescent dye. The diffusion of
dye was recorded as follows: immediate transfer (less than 30 s),
delayed transfer (30 s to 3 min) and no transfer (more than 3 min). In
the GJ channels composed of Cx31-WT subunits, LY was almost imme-
diately transferred after injection (Fig. 1A; n=18/21). The Cx26-p.D46E
negative control [22] did not display intercellular dye transfer (data not
shown; n=24/25). Similarly, the LY dye did not diffuse through any GJ
channels that were composed of Cx31-p.V27M or Cx31- p.V84I (Fig. 1B;
n=36/40 and Fig. 1C; n=41/47, respectively). For the Cx31-p.V43M
variant, LY was either immediately transferred (n=18/29) or showed
partly delayed transfer (Fig. 1D; n=9/29). These data indicate that GJ
channels composed of either Cx31-p.V27M or Cx31-p.V84I proteins
(homozygotes) cannot function in the transfer of substances. We per-
formed an additional biochemical coupling test to assess the heterozy-
gous conditions using Cx31-WT with Cx31-p.V27M or Cx31-p.V84IFig. 1. Diffusion of LY through the GJ of Cx31-WT, Cx31 variants and hybrid of Cx31-WT and
bordering the two cells in HEK293 cells expressing mCherry. Individual cells were microinjec
LY. The Cx31-WT (A) transferred LY through GJs from the injected cell to the neighboring cel
Cx31-p.V43M (D) variant transferred LY slowly. Both the Cx31-WT-EGFP/Cx31-p.V27M-m
transfer.which greatly inﬂuenced the ability to transfer substances as homozy-
gotes, because they were all found as heterozygotes in the patients. The
HEK293 cells were co-transfected with equal amounts of Cx31-WT and
Cx31-p.V27M (or Cx31-p.V84I) plasmid DNA. The hybrid GJ consisting
of Cx31-WT/Cx31-p.V27M transferred LY slowly (Fig. 1E; n=31/35)
and occasionally did not transfer the dye at all (n=4/35). In the Cx26-
WT/Cx26-p.D46E which served as a control and Cx31-WT/Cx31-p.V84I
hybrid GJ, LY was transferred slowly and weakly (data not shown and
Fig. 1F; n=10/23 and n=17/37, respectively) or not at all (n=13/23
and n=17/37, respectively).
HeLa cells were transfected with Cx30-WT and two Cx30-MT
constructs tagged with EGFP, a green ﬂuorescent protein marker, and
PI was used as the dye for visualizing transfer. The Cx30-WT-EGFP
and two Cx30-MT-EGFP proteins were localized on the cell membrane
and formed GJs. For the biochemical coupling test, PI was relatively
easily transferred through GJ channels composed of Cx30-WT subunits
(Fig. 2A; n=25/30), but was not completely transferred through the
Cx26-p.D46E channels (data not shown; n=20/20). PI transfer through
GJ channels consisting only of Cx30-p.A40V subunits (Fig. 2B; n=32/
40) occurred at a ratio similar to that of Cx30-WT, whereas approxi-
mately half of the GJ channels composed of Cx31-p.I248V transferred
PI (Fig. 2C; n=17/31).3.3. Assays for measuring ionic coupling
After identiﬁcation of the GJs expressed in transfected cells, the
ability of the GJs to intercellularly transfer Ca2+ ions was examined
using calcium imaging analysis. The mechanically stimulated cell was
referred to as cell #1, its GJ-forming neighboring cell was cell #2, and
an untransfected neighboring cell used as a control was cell #3. The
fura-2 signals showed the mechanically elicited intracellular Ca2+
concentration in the stimulated cell (#1) and neighboring cells (#2) in
real time. Untransfected cells did not display intercellular Ca2+ transfer
to neighboring cells from mechanically stimulated cells.Cx31 variants in HEK293 cells. Arrows indicate the presence of GJs at the cell membrane
ted with LY, and intercellular diffusion of dye was monitored for 3 min after injection of
l, whereas neither Cx31-p.V27M (B) nor the Cx31-p.V84I (C) variant transferred LY. The
Cherry (E) and Cx31-WT-EGFP/Cx31-p.V84I-mCherry (F) hybrid GJs showed delayed
Fig. 2. Diffusion of PI through GJ of Cx30-WT and Cx30 variants in HeLa cells. Arrows indicate the GJs as identiﬁed by EGFP in the HeLa cells, which were monitored for 5 min after
injection of PI. Intercellular diffusion of the dye is shown between two cells expressing Cx30-WT-EGFP (A) and Cx30-p.A40V-EGFP (B). The Cx30-p.I248V (C) variant transferred PI
in about half of all cells.
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of intracellular Ca2+ in the mechanically stimulated cells led to an
increase in the Ca2+ concentration in the coupled neighboring
cell (Fig. 3A; n=44/56). In GJs composed of the Cx31-p.V43M variant,
the incidence of no transfer (n=19/32) was slightly higher than that
of transfer (Fig. 3B; n=13/32). In cells expressing the Cx31-p.V27Mor
Cx31-p.V84I variants, Ca2+ was rarely transferred (Fig. 3C; n=15/20Fig. 3. Diffusion of calcium ions through GJs of Cx31-WT, Cx31 variants and hybrids of the C
cell #2 is the cell that forms a GJ with cell #1 and cell #3 is an untransfected cell used as a c
tration of cell #1 was increased, that of cell #2 immediately increased. The Cx31-p.V43M-EG
transfected with Cx31-p.V27M-EGFP (C) or Cx31-p.V84I-EGFP (D), the intracellular Ca2+ co
#2 rarely increased. In both the Cx31-WT-mCherry/Cx31-p.V27M-EGFP (E) and Cx31-mCh
increased, and that of cell #2 was increased slowly.and Fig. 3D; n=35/50). This result indicates that GJs composed of
either the Cx31-p.V27M or the Cx31-p.V84I variant lost GJ-mediated
ionic coupling. Additional ionic coupling tests were performed for
heterozygotes composed of the Cx31-WT and Cx31-p.V27M or Cx31-
p.V84I variant. The Cx31-WT/Cx31-p.V27M heterozygote slowly trans-
ferred Ca2+ in half of the experiments (Fig. 3E; n=11/22), and
some GJs did not transfer Ca2+ at all (n=2/22). For the Cx31-WT/x31-WT and Cx31 variants in HEK293 cells. Cell #1 is the mechanically stimulated cell,
ontrol. The Cx31-WT-EGFP (A) construct showed that as the intracellular Ca2+ concen-
FP variant did not transfer calcium ions at all or transferred them slowly (B). In the cells
ncentration of cell #1 increased in response to mechanical stimulation, but that of cell
erry/Cx31-p.V84I-EGFP (F) hybrid GJ, the intracellular Ca2+ concentration cell #1 was
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(Fig. 3F; n=9/20) or not transferred at all (n=5/20).
In the Cx30-WT and the Cx30-p.A40V and Cx30-p.I248V variants,
intercellular Ca2+ was easily transferred (Fig. 4A; n=11/12, Fig. 4B;
n=13/15 and Fig. 4C; n=18/18, respectively).4. Discussion
The GJB3 and GJB6 genes, which are expressed in the inner ear,
are involved in nonsyndromic HL with a dominant or recessive inher-
itance pattern. Many studies of the GJB2 gene, which is a major
causative gene for autosomal recessive nonsyndromic HL in Caucasians,
have been performed to date, but little is known about the contributions
of GJB3 and GJB6 to genetic HL in humans. The GJB3 and GJB6 genes
are evolutionarily close to GJB2, and the expression pattern of GJB6 is
very similar to that of GJB2 in the inner ear. Considering the relation-
ships among these genes in terms of evolution and development, it is
possible that GJB3 and GJB6 are associated with HL in humans. Thus,Fig. 4. Diffusion of calcium ions through the GJ of Cx30-WT and Cx30 variants in HeLa cells.
an untransfected cell used as a control. The Cx30-WT-EGFP (A), Cx30-p.A40V-EGFP (B) and
tration of cell #1 increased, the Ca2+ concentration in cell #2 immediately increased.we performed functional and molecular genetic analyses with GJB3
and GJB6.
The molecular genetic analysis of the GJB3 and GJB6 genes in 215
Korean patients with nonsyndromic HL identiﬁed nine variants,
including four novel variants. Four of these variants were identiﬁed
only in the patient group and not the control group. The p.V84I
variant in the GJB3 genewas detectedwith a particularly high allele fre-
quency in our patients (1.65%, 7/424). The p.V84I variant (c.250G>A)
was ﬁrst identiﬁed as having a 0.87% (1/114) allele frequency in
the USA [23]. The p.V84I was also detected at low allele frequencies
(0.35%, 2/568 and 0.20%, 1/506, respectively) in two studies in China
[24,25]. These data indicate that p.V84I in the GJB3 gene occurs with a
high relative frequency in Korean patients compared with patients in
other countries.
Five different variantswere selected for functional studies, and three
of these variants (Cx31-p.V27M, Cx31-p.V84I and Cx30-p.A40V) were
predicted to be pathogenic because the mutations were only found
in patients and the residues were highly conserved among different
species. The effects of these mutations on Cx function have beenCell #1 is the mechanically stimulated cell, cell #2 forms a GJ with cell #1 and cell #3 is
Cx30-p.I248V-EGFP (C) constructs all showed that when the intracellular Ca2+ concen-
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substitution. Therefore, functional studies are critical in understanding
the pathogenic potential of the Cx30 and Cx31 mutations.
The results of the two functional studies indicated that the homo-
zygous Cx31-p.V27M GJ was not very efﬁcient at transferring either
Ca2+ ions or LY dye. The hybrid GJ composed of the Cx31-WT/Cx31-
p.V27M heterozygote showed a more delayed transfer capacity
compared to Cx31-WT in both the biochemical and ionic coupling
tests. The Cx31-p.V27M variant, ﬁrst discovered in the current study
is located in the equivalent position of p.V27I in the Cx26. It is consid-
ered that p.V27I in the Cx26 is a non-pathogenic variant in many
previous studies [26,27], but p.V27 was substituted with the different
amino acid in the Cx31. The size of methionine is larger than valine and
isoleucine, and this can affect the formation of the GJ. It has been reported
that the variants in the same position are substituted with different
amino acids in the case of p.W44C and p.W44S, p.R75W and p.R75Q,
p.M34T and p.M34A of Cx26, each variant showed different effects on
function of the GJ [28,29]. The p.R75Q had gap junction plaques at the
cell borders, but the p.R75Whad smaller plaques andmore intracellular
staining. In the co-expressing Cx30, p.W44C and p.R75W completely
inhibited neurobiotin transfer to neighboring cells, but the p.W44S
and p.R75Q partially inhibited. The p.M34T and p.M34A both formed
gap junction plaques, but dye transfer assays showed that the p.M34T
transfer dye through the gap junctions and the p.M34A had a signiﬁ-
cantly reduced permeability. The p.M34T did not interferewith the efﬁ-
cient formation of stable connexon hexamer, but the p.M34A reduced
channel permeability because of substitution of the original residue
with a smaller residue. Reducing the size of the side chain at this posi-
tion, it would lead to a partially closed channel. Different variants in
the same position or domain may alter different functional effect of Cx
through modiﬁcation of the three-dimensional structure of protein.
For Cx31-p.V43M, the homozygote was not able to function
normally in the transfer of substances, especially in the ionic coupling
test, whereas the heterozygote functioned almost normally. These results
indicate that homozygous Cx31-p.V43M can be pathogenic, but hetero-
zygous Cx31-p.V43M is nonpathogenic, which is the form detected in
the patients of this study.
In the case of Cx31-p.V84I, the results of biochemical and ionic cou-
pling tests were similar to those of Cx31-p.V27M under homozygous
conditions, but results from the hybrid Cx31-WT/Cx31-p.V84I GJ were
somewhat different than the results from the hybrid Cx31-WT/Cx31-
p.V27M GJ. The Cx31-WT/Cx31-p.V84I heterozygote showed a lack of
transfer or delayed transfer in both the biochemical and ionic coupling
tests, whereas the Cx31-WT/Cx31-p.V27M heterozygote primarily
showed a delayed transfer or transfer. The Cx31-p.V84I variant is
more functionally deﬁcient than Cx31-p.V27M, and Cx31-p.V84I has
also been shown to have a deleterious effect in HL. The Cx26-p.V84L
mutation, which is at the equivalent amino acid position as the Cx31-
p.V84I mutation, deregulates the IP3 cascade, which is important in
the Ca2+ pathway [30]. This previous study supports the idea that
Cx31-p.V84I is a pathogenic variant. The p.V84I (c.250A>G) mutation
in GJB3was detected in several previous studies, but functional studies
were not conducted. Our study was therefore the ﬁrst to assess the
function of the Cx31-p.V84I variant.
The Cx30-p.A40V variant functioned normally in the biochemical and
ionic coupling tests, indicating that Cx30-p.A40V is a nonpathogenic
variant that produces a functionally null protein that does not interfere
with normal GJ function. However, it has recently been shown that
Cx30-p.A40V causes Cx30 protein accumulation in the Golgi body rather
than in the cytoplasmic membrane [31]. These differences in putative
functionmay be due to the different experimental methods. The recently
reported study employed the Tet-On system to regulate gene expression,
and this systemmight yielddifferent results than those found in our study
in terms of the expression level of the Cx gene and the effect onHeLa cells.
The Cx30-p.I248V variant functioned normally in the ionic coupling
test and had a small effect on biochemical coupling. GJs allow smallmolecules with molecular weights of less than 1 kDa to be transferred.
The molecular weight (MW) of the PI dye used to test the biochemical
coupling is 650 Da, whereas the MW of the calcium ions used to test
the ionic coupling is 40.078 Da. This discrepancy in the results between
the two functional studies for Cx30-p.I248V can be caused by differ-
ences of MW and characteristics of the substances that passed between
the cells through GJs. Additional studies using a substance that is small-
er than the PI dye such as inositol 1,4,5-trisphosphate (IP3) [32], are
needed to conﬁrm the effects of the Cx30-p.I248V variant in biochemi-
cal coupling tests. However, the effect of the Cx30-p.I248V homozygote
was weak in the biochemical coupling test and absent in the ionic
coupling test using calcium ions. The calcium ions have a MW similar
to that of potassium (MW: 39.098 Da), which is recycled through the
GJs during auditory transduction. We conclude from these studies that
Cx30-p.I248V is a nonpathogenic variant.
Based on our data, the variants of the GJB6 gene are all nonpathogenic
variants. To date, there have been several studies involving various
combinations of Cx30 and Cx26 [28,33]. A 309-kb deletion in the GJB6
gene is the second most frequent mutation that causes prelingual
deafness in the Spanish population, and mutations in the GJB2 and GJB6
complex can result in a monogenic or digenic pattern of inheritance of
prelingual deafness [34,35]. Our study identiﬁed only two variants of
the GJB6 gene, and none of our patients were carrying a deletion in the
GJB6 gene. Until now, there have been no reports of mutations in the
GJB6 gene in Korean patients with HL. Together, our studies indicate
that the GJB6 gene is not the main causative gene associated with HL in
Korean patients. This information will be valuable in understanding the
pathogenic roles of Cx31 and Cx30 mutations associated with HL and in
applying gene therapy or early diagnosis.
Supplementary materials related to this article can be found online
at http://dx.doi.org/10.1016/j.bbadis.2012.05.009.
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